Skip to main content
Log in

Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinosonism

  • CLINICAL TRIALS
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract.

Rationale: Poor specificity of face-value endpoints and the poor sensitivity of gross clinical examination may have militated against demonstrating prophylaxis by selegiline.

Methods:

Objective measures of the four cardinal signs were used as primary outcome criteria in a randomised, double-blind, placebo-controlled, parallel group study of selegiline monotherapy in 25 newly diagnosed elderly sufferers from idiopathic parkinsonism, stratified for sex and Hoehn and Yahr functional staging.

Results:

There was a significant interaction between time and nature of treatment with respect to rigidity. The effect of time during active treatment was highly significant: rigidity decreased by 1.3 % per week. The worsening of rigidity on placebo was not statistically significant. Neuronal rescue is a possible explanation for the long term, progressive improvement produced by selegiline.

No significant treatment effect was seen on the other cardinal signs. However, there was a significant quadratic time trend for arousal on active treatment suggesting tolerance to this effect.

Conclusion:

The difference in time course between the psychostimulant and physical effects suggests more than one mode of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 7 December 1994 /Accepted in revised form: 12 September 1995

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirollos, C., Charlett, A., Bowes, S. et al. Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinosonism. E J Clin Pharmacol 50, 7–18 (1996). https://doi.org/10.1007/s002280050062

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050062

Navigation